Sermorelin and Tamoxifen Interaction

Monitor
Mechanism-based 47% confidence

Sermorelin and Tamoxifen have an interaction requiring monitoring for interaction with 47% confidence. Both Sermorelin and Tamoxifen act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Both compounds affect the pituitary, so monitoring these systems is recommended.

Compound Profiles

Sermorelin

GHRH Analog | Growth Hormone Releasing Hormone

Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..

Half-life: 10-12 minutes Typical dose: 200-300mcg per dose (up to 500mcg for athletic performance) growth hormone, weight loss
estrogen receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Half-life: ~5-7 days Typical dose: 20-40mg oral daily pct
cyp3a4estrogen receptor anticoagulantcarcinogenic riskhepatotoxicpct agent
View full profile

Combined Organ Load

Pituitary
low
GI Tract
low
Gonads
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Sermorelin, Tamoxifen). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Sermorelin, Tamoxifen). Monitor accordingly.

Frequently Asked Questions

Can I take Sermorelin with Tamoxifen?

Yes, but with caution. Both Sermorelin and Tamoxifen act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. Regular monitoring is advised.

Is Sermorelin and Tamoxifen safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, teratogenic. Monitor accordingly.

What are the interactions between Sermorelin and Tamoxifen?

Both Sermorelin and Tamoxifen act on estrogen receptors. Receptor competition may reduce effectiveness of one or both. Using multiple SERMs simultaneously is generally not recommended — choose one. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time Sermorelin and Tamoxifen?

Sermorelin has a half-life of 10-12 minutes and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Sermorelin vs Tamoxifen

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.